Cellectar Biosciences, Inc. Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Cellectar Biosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2025.
  • Cellectar Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2025 was -$4.44M, a 69.7% increase year-over-year.
  • Cellectar Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2025 was -$18.9M, a 62.4% increase year-over-year.
  • Cellectar Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$44.6M, a 4.23% decline from 2023.
  • Cellectar Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$42.8M, a 34.5% decline from 2022.
  • Cellectar Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$31.8M, a 31.8% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)

Cellectar Biosciences, Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$18.9M -$4.44M +$10.2M +69.7% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-13
Q2 2025 -$29.1M -$5.45M -$4.53M -493% Apr 1, 2025 Jun 30, 2025 10-Q 2025-11-13
Q1 2025 -$24.5M -$6.6M +$20M +75.2% Jan 1, 2025 Mar 31, 2025 10-Q 2025-11-13
Q4 2024 -$44.6M -$2.36M +$5.53M +70.1% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-13
Q3 2024 -$50.1M -$14.7M +$2.86M +16.3% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-13
Q2 2024 -$53M -$919K +$9.26M +91% Apr 1, 2024 Jun 30, 2024 10-Q 2025-11-13
Q1 2024 -$62.2M -$26.6M -$19.5M -271% Jan 1, 2024 Mar 31, 2024 10-Q 2025-11-13
Q4 2023 -$42.8M -$7.88M +$4.53M +36.5% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-13
Q3 2023 -$47.3M -$17.5M -$10M -133% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-18
Q2 2023 -$37.3M -$10.2M -$4.54M -80.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-18
Q1 2023 -$32.7M -$7.19M -$951K -15.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-18
Q4 2022 -$31.8M -$12.4M -$6.49M -110% Oct 1, 2022 Dec 31, 2022 10-K/A 2024-10-29
Q3 2022 -$25.3M -$7.51M -$1.69M -29.1% Jul 1, 2022 Sep 30, 2022 10-K/A 2024-10-29
Q2 2022 -$23.6M -$5.64M +$393K +6.52% Apr 1, 2022 Jun 30, 2022 10-K/A 2024-10-29
Q1 2022 -$24M -$6.24M +$117K +1.85% Jan 1, 2022 Mar 31, 2022 10-K/A 2024-10-29
Q4 2021 -$24.1M -$5.92M -$2.3M -63.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 -$21.8M -$5.82M -$1.91M -48.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$19.9M -$6.03M -$2.42M -66.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-03
Q1 2021 -$17.5M -$6.36M -$2.4M -60.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-03
Q4 2020 -$15.1M -$3.62M -$235K -6.96% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-21
Q3 2020 -$14.9M -$3.91M -$5.76K -0.15% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$14.9M -$3.61M -$424K -13.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-08
Q1 2020 -$14.4M -$3.96M -$336K -9.28% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-08
Q4 2019 -$14.1M -$3.38M +$448K +11.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-02
Q3 2019 -$14.5M -$3.9M -$889K -29.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$13.7M -$3.19M -$267K -9.14% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-09
Q1 2019 -$13.4M -$3.62M -$146K -4.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-09
Q4 2018 -$13.2M -$3.83M +$251K +6.16% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-09
Q3 2018 -$13.5M -$3.01M +$456K +13.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$13.9M -$2.92M +$201K +6.43% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-12
Q1 2018 -$14.1M -$3.48M -$584K -20.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-12
Q4 2017 -$13.6M -$4.08M -$1.49M -57.8% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-26
Q3 2017 -$12.1M -$3.47M -$1.18M -51.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$10.9M -$3.12M -$989K -46.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-11-13
Q1 2017 -$9.9M -$2.89M -$3.72M -451% Jan 1, 2017 Mar 31, 2017 10-Q 2018-11-13
Q4 2016 -$6.18M -$2.59M -$3.54M -372% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-21
Q3 2016 -$2.64M -$2.29M -$429K -23.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$2.22M -$2.13M +$154K +6.72% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$2.37M $825K +$3.13M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$5.5M $951K +$4.3M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-15
Q3 2015 -$9.79M -$1.86M -$2.18M -673% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$7.61M -$2.29M -$201K -9.62% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$7.41M -$2.3M +$642K +21.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 -$8.05M -$3.35M +$602K +15.2% Oct 1, 2014 Dec 31, 2014 10-K/A 2016-10-20
Q3 2014 -$8.65M $324K +$1.64M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$10.3M -$2.09M -$21.4K -1.04% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 -$10.3M -$2.94M +$510K +14.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-20
Q4 2013 -$10.8M -$3.95M -$1.79M -83.1% Oct 1, 2013 Dec 31, 2013 10-K 2015-05-20
Q3 2013 -$8.99M -$1.32M +$737K +35.9% Jul 1, 2013 Sep 30, 2013 10-Q 2015-05-20
Q2 2013 -$9.73M -$2.06M +$166K +7.46% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 -$9.89M -$3.45M -$1.1M -46.5% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 -$8.8M -$2.16M -$191K -9.72% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-19
Q3 2012 -$8.61M -$2.05M -$143K -7.5% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 -$8.46M -$2.23M +$364K +14% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-12
Q1 2012 -$8.83M -$2.36M -$1.39M -144% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$7.44M -$1.97M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-19
Q3 2011 -$1.91M -$1.21M -173% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 -$2.6M -$973K -60% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 -$965K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q3 2010 -$700K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 -$1.62M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12

Cellectar Biosciences, Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$44.6M -$1.81M -4.23% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-13
2023 -$42.8M -$11M -34.5% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-13
2022 -$31.8M -$7.67M -31.8% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-10-29
2021 -$24.1M -$9.03M -59.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 -$15.1M -$1M -7.11% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-21
2019 -$14.1M -$854K -6.45% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-02
2018 -$13.2M +$323K +2.38% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-09
2017 -$13.6M -$7.38M -119% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-26
2016 -$6.18M -$685K -12.5% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-21
2015 -$5.5M +$2.56M +31.8% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-15
2014 -$8.05M +$2.73M +25.3% Jan 1, 2014 Dec 31, 2014 10-K/A 2016-10-20
2013 -$10.8M -$1.99M -22.6% Jan 1, 2013 Dec 31, 2013 10-K 2015-05-20
2012 -$8.8M -$1.36M -18.3% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-19
2011 -$7.44M -$2.88M -63% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-19
2010 -$4.56M Jan 1, 2010 Dec 31, 2010 10-K 2014-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.